Effects of radiofrequency exposure on in vitro blood-brain barrier permeability in the presence of magnetic nanoparticles

dc.contributor.authorSenturk, Fatih
dc.contributor.authorCakmak, Soner
dc.contributor.authorKocum, Ismail Cengiz
dc.contributor.authorGumusderelioglu, Menemse
dc.contributor.authorOzturk, Goknur Guler
dc.contributor.pubmedID35134610en_US
dc.date.accessioned2022-11-15T12:00:58Z
dc.date.available2022-11-15T12:00:58Z
dc.date.issued2022
dc.description.abstractThe blood-brain barrier (BBB) remains a major obstacle for the delivery of drugs in the treatment of many neurological diseases. In this study, we aimed to investigate the effects of radiofrequency electromagnetic fields (RF-EMFs) on the permeability of an in vitro BBB model under RF exposure alone, or in the presence of nanoparticles (NPs). For this purpose, an in vitro BBB model was established by seeding human umbilical vein endothelial cells (HUVECs) and human glioblastoma cell line (T98G) on the apical and basolateral sides of the transwell membrane, respectively. The integrity of the BBB model was confirmed by measuring transendothelial electrical resistance (TEER), and a fluorescein isothiocyanate (FITC)-dextran permeability assay was performed when the resistance reached 120 U cm(2). After the RFfield exposure (13.56 MHz, 80 W, 10 min), we found that FITC-dextran transported across the in vitro BBB was increased 10-fold compared to FITC-dextran transported without an RF-field. This notable phenomenon, which can be called the burst permeability RF effect (BP-RF), has been proposed for the first time in the literature. Subsequently, the effect of the RF-field on BBB permeability was also investigated in the presence of superparamagnetic iron oxide nanoparticles (SPIONs) and magnetic poly(lactic-co-glycolic acid)-polyethylene glycol (PLGA-b-PEG) nanoparticles (m-PNPs). It was found that the amount of both transported NPs on the basolateral sides increased after exposure to the RF-field. As a result, the RFfield can be applied simultaneously during treatment with clinical agents or nanocarriers, improving the permeability of the BBB, which may contribute to therapeutic efficacy of many drugs that are used in neurological diseases. (c) 2022 Elsevier Inc. All rights reserved.en_US
dc.identifier.endpage97en_US
dc.identifier.issn0006-291Xen_US
dc.identifier.scopus2-s2.0-85124185661en_US
dc.identifier.startpage91en_US
dc.identifier.urihttp://hdl.handle.net/11727/8109
dc.identifier.volume597en_US
dc.identifier.wos000755174800001en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.bbrc.2022.01.112en_US
dc.relation.journalBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBlood-brain barrier permeabilityen_US
dc.subjectRF-Fielden_US
dc.subjectFITC-Dextranen_US
dc.subjectMagnetic nanoparticlesen_US
dc.titleEffects of radiofrequency exposure on in vitro blood-brain barrier permeability in the presence of magnetic nanoparticlesen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: